Lexeo is attending the 6th Zurich International Symposium on arrhythmogenic cardiomyopathies. This premier event brings together leading experts to discuss the latest advancements in the diagnosis and treatment of arrhythmogenic cardiomyopathy, also known as ACM or ARVC. Lexeo is proud to sponsor this symposium, furthering our commitment to innovation and excellence in cardiology. We look forward to engaging with the global medical community to advance care for those affected by ACM.
Lexeo Therapeutics’ Post
More Relevant Posts
-
Navigate the #InterventionalCardiology match process with ease! Join our collaborative webinar with the American College of Cardiology on July 30 and learn the details of the new IC match process. ➡️Learn more and register: https://lnkd.in/gxZT9iZV #SCAIFellowshipMatch
-
-
Dive into the future of cardiology with MedAxiom and American College of Cardiology! 🚀 Join the conversation as we explore the evolving landscape of cardiovascular care, from value-based approaches to navigating the impact of private equity. 💡 Tune in to the ACCEL audio interview featuring Jerry Blackwell, MD, MBA, FACC, and Joseph Marine, MD, MBA, FACC, for insights on shaping the future of patient-centric healthcare: https://hubs.li/Q02tRZ8D0 #CardiologyFuture #ValueBasedCare #HealthcareInnovation
-
-
Do you want to know more about how to delay Subclinical AF and its progression to Clinical AF in your CIED patients? Read this paper 👇
Thrilled to announce that the groundbreaking B3 study results have been officially published in #Europace! 🚀 The B3 trial included 1,210 patients across 53 centers in Europe and the Asia-Pacific region, monitoring them for a three-year duration. It is the first large, randomized clinical trial that evaluated the benefits of Closed Loop Stimulation (CLS) in terms of clinical endpoints such as clinically relevant #AtrialFibrillation and #stroke. Curious to delve deeper into the findings? Dive into the study here: https://ow.ly/4ybt50Sv9kE #ClinicalInnovation #HealthcareAdvancement European Society of Cardiology
-
Launching something cool today, close to the heart you may say. When every move counts and every decision is critical, we're there – to help interventional cardiology teams stay close to the heart ❤️ Discover how our interventional cardiology solutions drive better heart care: https://lnkd.in/gMH_DMbN
-
Join us for our Annual Cardiology CPD Dinner Meeting on the 12th June 2024. An event not to be missed! RSVP Here: https://lnkd.in/gMrMMM7W Presenters Dr Calvin Hsieh, Cardiologist & Electrophysiologist Dr Ee-May Chia, General Cardiologist Topics: - Overview on the latest updates on congestive cardiac failure treatment - the role of new medication classes in context of the established medications. - The importance of effective treatment of atrial fibrillation in the context of congestive cardiac failure - The role of device therapy and how the type of device implant can affect the outcome of this complex group of patients
-
-
Global Director Patient Engagement | Enthusiastic of Patient-Centered Research to elevate the patient communities' voice
Today, at the European Society of Cardiology Congress, Global Heart Hub will present a poster from their study: Insights from the Patients living with Elevated Cholesterol (IPEC). It is the patient perspective being presented by patients to physicians about the importance of decision-making when patients are first diagnosed with hypercholesterolemia. Delighted to see the patient voice present at medical congresses with such relevance! #patientengagement #patientvoice #patientdata #globalhearthub #ipec
We’re looking forward to our poster presentation at the European Society of Cardiology Congress today. We’re presenting the findings from our Insights from the Patients living with Elevated Cholesterol (IPEC) study and sharing the importance of shared decision-making when patients are first diagnosed with hypercholesterolemia. Can’t make it? Learn more about the IPEC study here: https://lnkd.in/gm2AqrPn #ESCCongress #IPEC
-
-
Join us for our Annual Cardiology CPD Dinner Meeting on the 24th July 2024. An event not to be missed! RSVP Here: https://lnkd.in/gnwaCqF2 Presenters Dr Calvin Hsieh, Cardiologist & Electrophysiologist Dr Ee-May Chia, General Cardiologist Topics: - Overview on the latest updates on congestive cardiac failure treatment - the role of new medication classes in context of the established medications. - The importance of effective treatment of atrial fibrillation in the context of congestive cardiac failure - The role of device therapy and how the type of device implant can affect the outcome of this complex group of patients
-
-
Join us for our Annual Cardiology CPD Dinner Meeting on the 12th June 2024. An event not to be missed! RSVP Here: https://lnkd.in/gP4UR3Pd Presenters Dr Calvin Hsieh, Cardiologist & Electrophysiologist Dr Ee-May Chia, General Cardiologist Topics: - Overview on the latest updates on congestive cardiac failure treatment - the role of new medication classes in context of the established medications. - The importance of effective treatment of atrial fibrillation in the context of congestive cardiac failure - The role of device therapy and how the type of device implant can affect the outcome of this complex group of patients
-
-
Thrilled to announce that the groundbreaking B3 study results have been officially published in #Europace! 🚀 The B3 trial included 1,210 patients across 53 centers in Europe and the Asia-Pacific region, monitoring them for a three-year duration. It is the first large, randomized clinical trial that evaluated the benefits of Closed Loop Stimulation (CLS) in terms of clinical endpoints such as clinically relevant #AtrialFibrillation and #stroke. Curious to delve deeper into the findings? Dive into the study here: https://ow.ly/4ybt50Sv9kE #ClinicalInnovation #HealthcareAdvancement European Society of Cardiology
-
New clinical data supporting the value of image-guided VT ablations! A recent article in the Heart Rhythm Journal confirmed a correlation between VT isthmus location and areas of ventricular wall thinning. "If the reentrant VT isthmus could be completely and accurately mapped from imaging done prior to EP study, then the ablation procedure would be simplified and the procedure time shortened with better efficacy and safety.” Read the full article here! https://lnkd.in/ggEhHWKC Heart Rhythm Society European Society of Cardiology Edward Ciaccio Nicolas Cedilnik Henry Hsia Angelo Biviano Hasan Garan Hirad Yarmohammadi #inheart
-
